Definity
ApprovedCompleted 0 watching 0 views this week🔥 Hot
82
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 2✓
Phase 35
ApprovedIndication / Disease
Pulmonary Heart Disease
Conditions
Pulmonary Heart Disease
Trial Timeline
Jul 1, 2009 → Dec 1, 2009
NCT ID
NCT00918866About Definity
Definity is a approved stage product being developed by Lantheus Holdings for Pulmonary Heart Disease. The current trial status is completed. This product is registered under clinical trial identifier NCT00918866. Target conditions include Pulmonary Heart Disease.
Hype Score Breakdown
Clinical
30
Activity
20
Company
7
Novelty
10
Community
12
Clinical Trials (6)
| NCT ID | Phase | Status |
|---|---|---|
| NCT05247541 | Phase 2/3 | Completed |
| NCT03571672 | Phase 3 | Completed |
| NCT03243942 | Phase 2 | Completed |
| NCT01062178 | Phase 2 | Completed |
| NCT00918866 | Approved | Completed |
| NCT01005212 | Pre-clinical | Completed |
Competing Products
20 competing products in Pulmonary Heart Disease